Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences (PRHSX)

100.69 0.93 ( 0.93%)
At close: October 18 at 8:01 PM EDT
Loading Chart for PRHSX
DELL
  • Previous Close 99.76
  • YTD Return 14.31%
  • Expense Ratio 0.80%
  • Category Health
  • Last Cap Gain 49.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 15.44B
  • Beta (5Y Monthly) 0.74
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 48.40%
  • Last Dividend 0.05
  • Inception Date Dec 29, 1995

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

T. Rowe Price

Fund Family

Health

Fund Category

15.44B

Net Assets

1995-12-29

Inception Date

Performance Overview: PRHSX

View More

Trailing returns as of 10/18/2024. Category is Health.

YTD Return

PRHSX
14.31%
Category
7.95%
 

1-Year Return

PRHSX
23.31%
Category
30.16%
 

3-Year Return

PRHSX
1.84%
Category
16.10%
 

5-Year Return

PRHSX
12.66%
Category
15.71%
 

People Also Watch

Holdings: PRHSX

View More

Top 9 Holdings (43.72% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 10.50%
UNH
UnitedHealth Group Incorporated 7.20%
TMO
Thermo Fisher Scientific Inc. 4.97%
ISRG
Intuitive Surgical, Inc. 4.72%
DHR
Danaher Corporation 4.00%
SYK
Stryker Corporation 3.55%
MRK
Merck & Co., Inc. 3.04%
REGN
Regeneron Pharmaceuticals, Inc. 2.89%
ELV
Elevance Health, Inc. 2.86%

Sector Weightings

SectorPRHSX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related Mutual Fund News

View More

Top Mutual Funds